MDMA-Assisted Therapy is Less Effective if You Take Antidepressants
This DoubleBlind article summarizes research suggesting that a history of antidepressant use may reduce the effectiveness of MDMA-assisted therapy. It covers the relationship between SSRIs and MDMA in the treatment of PTSD.
Provider
Details
Enrollment
Course Overview
This DoubleBlind article explains findings from research on how prior antidepressant use may affect outcomes in MDMA-assisted therapy. It focuses on the interaction between MDMA and commonly prescribed SSRIs, and why that interaction matters for psychedelic psychotherapy. The piece is relevant for readers interested in PTSD treatment, antidepressants, and the clinical development of MDMA. It presents a research-focused overview rather than a step-by-step course format. The article also places the topic in the context of ongoing clinical study of MDMA for trauma and the need to understand how it may work alongside or after antidepressant use.
Who is this for?
Readers interested in psychedelic therapy, PTSD treatment research, and the interaction between MDMA and antidepressants.
About the Provider
Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.
View Double Blind profileCourse Details
- PricePrice on request
- FormatSelf-paced
- Lifecycle statusNo New Dates
- SkillsIntegrationPsychotherapyPsilocybin TherapyMDMA-Assisted TherapyMicrodosingUnderstanding MDMA-assisted therapy researchRecognizing the role of SSRIs in treatment outcomesInterpreting psychedelic therapy safety considerationsEvaluating research on PTSD treatmentsUnderstanding research on MDMA-assisted therapyInterpreting information about SSRIs and MDMA interactionsReviewing topics related to PTSD treatmentReading research-focused psychedelic medicine coverageUnderstanding the relationship between MDMA and SSRIs
- Categories
Related Courses
View all coursesAre Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?
By Double Blind
An article examining whether ketamine clinics could serve as a model for future legal psychedelic therapy. It discusses current ketamine clinic practices, emerging regulation questions, and how clinics are preparing for MDMA and psilocybin services.
Certificate in Psychedelic-Assisted Therapies & Research | Ciisciis Logociis Logo
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Certificate in Psychedelic-Assisted Therapies and Research
By Fluence
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.